We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+35.4%
1 Year Est. Return
+158.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$268M
AUM Growth
+$45.6M
Cap. Flow
+$18.2M
Cap. Flow %
6.78%
Top 10 Hldgs %
33.7%
Holding
508
New
146
Increased
78
Reduced
73
Closed
186

Sector Composition

1 Technology 44.62%
2 Healthcare 29.67%
3 Financials 9.04%
4 Consumer Discretionary 3.92%
5 Energy 3.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROIV icon
451
Roivant Sciences
ROIV
$24.8B
-14,121
Closed -$363K
RVPH
452
CALL
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
-57
Closed -$228
RXRX icon
453
CALL
Recursion Pharmaceuticals
RXRX
$1.56B
-1,999
Closed -$20
RYTM icon
454
Rhythm Pharmaceuticals
RYTM
$7.31B
-1,446
Closed -$155K
RZLT icon
455
Rezolute
RZLT
$444M
-72,641
Closed -$171K
FLNA
456
PUT
Filana Therapeutics
FLNA
$51.2M
-30
Closed -$1.63K
SBCF icon
457
Seacoast Banking Corp of Florida
SBCF
$3.3B
-16,373
Closed -$514K
SLNO
458
CALL
DELISTED
Soleno Therapeutics
SLNO
-143
Closed -$425
SLNO
459
DELISTED
Soleno Therapeutics
SLNO
-7,416
Closed -$343K
SLV icon
460
CALL
iShares Silver Trust
SLV
$27.1B
-35
Closed -$2.12K
SNPS icon
461
Synopsys
SNPS
$73.6B
-2,755
Closed -$1.29M
SOFI icon
462
CALL
SoFi Technologies
SOFI
$22.2B
-94
Closed -$6.06K
STOK icon
463
Stoke Therapeutics
STOK
$1.81B
-4,576
Closed -$145K
TARA icon
464
Protara Therapeutics
TARA
$230M
-10,733
Closed -$57.2K
TBBK icon
465
The Bancorp
TBBK
$2.85B
-25,259
Closed -$1.71M
TCOM icon
466
Trip.com Group
TCOM
$26.7B
-2,434
Closed -$175K
TERN
467
CALL
DELISTED
Terns Pharmaceuticals
TERN
-147
Closed -$464K
TFC icon
468
Truist Financial
TFC
$65.4B
-18,710
Closed -$921K
TGTX icon
469
PUT
TG Therapeutics
TGTX
$8.4B
-265
Closed -$24.2K
THC icon
470
Tenet Healthcare
THC
$16.8B
-2,499
Closed -$497K
TRMD icon
471
TORM
TRMD
$2.91B
-30,000
Closed -$599K
TSLA icon
472
CALL
Tesla
TSLA
$1.43T
-7
Closed -$130
TVTX icon
473
Travere Therapeutics
TVTX
$5.27B
-3,291
Closed -$126K
TVTX icon
474
PUT
Travere Therapeutics
TVTX
$5.27B
-134
Closed -$13.1K
TWLO icon
475
CALL
Twilio
TWLO
$31.4B
-15
Closed -$5.09K

Similar funds

Persistent Asset Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Persistent Asset Partners held 508 positions worth $268M, up 20% from $223M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Persistent Asset Partners deployed $18.2M of net new capital in Q1 2026, opening 146 new positions and adding to 78 existing holdings. Its largest new stake was Tower Semiconductor: 67,608 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Terns Pharmaceuticals, an estimated $2.78M trimmed.

  • Persistent Asset Partners's largest Q1 2026 buy was Tower Semiconductor: 67,608 shares worth $11.9M.
  • Persistent Asset Partners added most to Lumentum in Q1 2026, an estimated $8.24M increase.
  • Persistent Asset Partners's biggest Q1 2026 reduction was Terns Pharmaceuticals, cutting an estimated $2.78M.
  • Persistent Asset Partners fully exited Centene in Q1 2026, selling an estimated $9.07M.
  • Persistent Asset Partners's ten largest holdings make up 34% of its $268M portfolio in Q1 2026.
  • Persistent Asset Partners opened 146 new positions and closed 186 in Q1 2026.
  • Persistent Asset Partners's portfolio value rose 20% quarter-over-quarter to $268M.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.